Draft Guidance on NDIN Master Files for Dietary Supplements - fda.gov
FDA issued draft guidance on NDIN Master Files for dietary supplements, clarifying submission procedures and data requirements for new dietary ingredient notifications.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on July 6, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers submitting NDINs should confirm how it applies to their specific situation before acting. There is a time constraint attached: Comments on draft guidance due within 60 days of publication (check Federal Register for exact date); final guidance expected within 1 year.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
FDA released draft guidance detailing how to use Master Files to reference proprietary safety data in NDIN submissions, potentially streamlining notifications but requiring adherence to new procedural expectations.
Who it affects
Supplement brands, contract manufacturers, private-label sellers, ingredient suppliers submitting NDINs
What you must do
Review draft guidance and assess whether current or planned NDIN submissions can leverage Master Files; prepare to comply with final guidance once published.
Deadline
Comments on draft guidance due within 60 days of publication (check Federal Register for exact date); final guidance expected within 1 year.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Dietary-Supplement Labeling (FDA)
- The Dietary Supplement Industry in the Time of Trump: Potential Opportunities and Pitfalls - Food and Drug Law Institute (FDLI)
- 60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - GlobeNewswire
- After 4-year review, FDA shuts down attempt to regulate CBD as a supplement and asks Congress for help - AgencyIQ by POLITICO
- US FDA New Dietary Ingredient Notification Submissions in the Last 4 Years - CIRS Group
- FDA's 2016 New Dietary Ingredient Draft Guidance - Food and Drug Law Institute (FDLI)